166 related articles for article (PubMed ID: 16882552)
1. Zonula occludens toxin synthetic peptide derivative AT1002 enhances in vitro and in vivo intestinal absorption of low molecular weight heparin.
Motlekar NA; Fasano A; Wachtel MS; Youan BB
J Drug Target; 2006 Jun; 14(5):321-9. PubMed ID: 16882552
[TBL] [Abstract][Full Text] [Related]
2. Effect of the six-mer synthetic peptide (AT1002) fragment of zonula occludens toxin on the intestinal absorption of cyclosporin A.
Song KH; Fasano A; Eddington ND
Int J Pharm; 2008 Mar; 351(1-2):8-14. PubMed ID: 17954018
[TBL] [Abstract][Full Text] [Related]
3. Modulation of gastrointestinal permeability of low-molecular-weight heparin by L-arginine: in-vivo and in-vitro evaluation.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
J Pharm Pharmacol; 2006 May; 58(5):591-8. PubMed ID: 16640827
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Oral Bioavailability of Low Molecular Weight Heparin Formulated With Glycyrrhetinic Acid as Permeation Enhancer.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
Drug Dev Res; 2006 Feb; 67(2):166-174. PubMed ID: 17710191
[TBL] [Abstract][Full Text] [Related]
5. The active Zot domain (aa 288-293) increases ZO-1 and myosin 1C serine/threonine phosphorylation, alters interaction between ZO-1 and its binding partners, and induces tight junction disassembly through proteinase activated receptor 2 activation.
Goldblum SE; Rai U; Tripathi A; Thakar M; De Leo L; Di Toro N; Not T; Ramachandran R; Puche AC; Hollenberg MD; Fasano A
FASEB J; 2011 Jan; 25(1):144-58. PubMed ID: 20852064
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of low-molecular-weight heparin using sodium caprate as absorption enhancer reaches therapeutic levels.
Motlekar NA; Srivenugopal KS; Wachtel MS; Youan BB
J Drug Target; 2005 Dec; 13(10):573-83. PubMed ID: 16390818
[TBL] [Abstract][Full Text] [Related]
7. Enhanced permeability of molecular weight markers and poorly bioavailable compounds across Caco-2 cell monolayers using the absorption enhancer, zonula occludens toxin.
Cox DS; Raje S; Gao H; Salama NN; Eddington ND
Pharm Res; 2002 Nov; 19(11):1680-8. PubMed ID: 12458674
[TBL] [Abstract][Full Text] [Related]
8. Effect of the biologically active fragment of zonula occludens toxin, delta G, on the intestinal paracellular transport and oral absorption of mannitol.
Salama NN; Fasano A; Lu R; Eddington ND
Int J Pharm; 2003 Jan; 251(1-2):113-21. PubMed ID: 12527181
[TBL] [Abstract][Full Text] [Related]
9. The influence of stabilizer and bioadhesive polymer on the permeation-enhancing effect of AT1002 in the nasal delivery of a paracellular marker.
Song KH; Eddington ND
Arch Pharm Res; 2012 Feb; 35(2):359-66. PubMed ID: 22370791
[TBL] [Abstract][Full Text] [Related]
10. Enhancing the permeation of marker compounds and enaminone anticonvulsants across Caco-2 monolayers by modulating tight junctions using zonula occludens toxin.
Cox DS; Gao H; Raje S; Scott KR; Eddington ND
Eur J Pharm Biopharm; 2001 Sep; 52(2):145-50. PubMed ID: 11522479
[TBL] [Abstract][Full Text] [Related]
11. Tetradecylmaltoside (TDM) enhances in vitro and in vivo intestinal absorption of enoxaparin, a low molecular weight heparin.
Yang T; Arnold JJ; Ahsan F
J Drug Target; 2005 Jan; 13(1):29-38. PubMed ID: 15848952
[TBL] [Abstract][Full Text] [Related]
12. The impact of AT1002 on the delivery of ritonavir in the presence of bioadhesive polymer, carrageenan.
Song KH; Eddington ND
Arch Pharm Res; 2012 May; 35(5):937-43. PubMed ID: 22644862
[TBL] [Abstract][Full Text] [Related]
13. Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery.
Song KH; Kim SB; Shim CK; Chung SJ; Kim DD; Rhee SK; Choi GJ; Kim CH; Kim K
Drug Des Devel Ther; 2015; 9():1815-23. PubMed ID: 25848218
[TBL] [Abstract][Full Text] [Related]
14. The influence of AT1002 on the nasal absorption of molecular weight markers and therapeutic agents when co-administered with bioadhesive polymers and an AT1002 antagonist, AT1001.
Song KH; Eddington ND
J Pharm Pharmacol; 2012 Jan; 64(1):30-9. PubMed ID: 22150669
[TBL] [Abstract][Full Text] [Related]
15. Enhanced nasal absorption of hydrophilic markers after dosing with AT1002, a tight junction modulator.
Song KH; Fasano A; Eddington ND
Eur J Pharm Biopharm; 2008 May; 69(1):231-7. PubMed ID: 18039562
[TBL] [Abstract][Full Text] [Related]
16. Modulation of intestinal tight junctions by Zonula occludens toxin permits enteral administration of insulin and other macromolecules in an animal model.
Fasano A; Uzzau S
J Clin Invest; 1997 Mar; 99(6):1158-64. PubMed ID: 9077522
[TBL] [Abstract][Full Text] [Related]
17. Mono-N-carboxymethyl chitosan (MCC), a polyampholytic chitosan derivative, enhances the intestinal absorption of low molecular weight heparin across intestinal epithelia in vitro and in vivo.
Thanou M; Nihot MT; Jansen M; Verhoef JC; Junginger HE
J Pharm Sci; 2001 Jan; 90(1):38-46. PubMed ID: 11064377
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of ZOT-derived peptide AT-1002, a tight junction regulator and absorption enhancer.
Gopalakrishnan S; Pandey N; Tamiz AP; Vere J; Carrasco R; Somerville R; Tripathi A; Ginski M; Paterson BM; Alkan SS
Int J Pharm; 2009 Jan; 365(1-2):121-30. PubMed ID: 18832018
[TBL] [Abstract][Full Text] [Related]
19. Zonula occludens toxin increases the permeability of molecular weight markers and chemotherapeutic agents across the bovine brain microvessel endothelial cells.
Karyekar CS; Fasano A; Raje S; Lu R; Dowling TC; Eddington ND
J Pharm Sci; 2003 Feb; 92(2):414-23. PubMed ID: 12532391
[TBL] [Abstract][Full Text] [Related]
20. Enhancing Oral Bioavailability of Cyclic RGD Hexa-peptides by the Lipophilic Prodrug Charge Masking Approach: Redirection of Peptide Intestinal Permeability from a Paracellular to Transcellular Pathway.
Schumacher-Klinger A; Fanous J; Merzbach S; Weinmüller M; Reichart F; Räder AFB; Gitlin-Domagalska A; Gilon C; Kessler H; Hoffman A
Mol Pharm; 2018 Aug; 15(8):3468-3477. PubMed ID: 29976060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]